Daniela Murgia

Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale

Angelo Antonini, Giovanni Abbruzzese, Luigi Ferini‐Strambi et al. · Neurological Sciences · 2012 · 145 citations · Full text

Life Sciences, Neurology, Neuroscience +10

A pilot trial of deferiprone for neurodegeneration with brain iron accumulation

Giovanni Abbruzzese, Giovanni Cossu, Manuela Balocco et al. · Haematologica · 2011 · 129 citations · Full text

Medicine, Neurology, Neuroscience +17

A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects

Francesca Piaggio, Vangelis Kondylis, Fabio Pastorino et al. · Journal of Controlled Release · 2015 · 109 citations

Medicine, Oncology, Pharmacology +17

Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): Results from a four years follow-up

Giovanni Cossu, Giovanni Abbruzzese, Gildo Matta et al. · Parkinsonism & Related Disorders · 2014 · 90 citations

Medicine, Neuroscience, Pharmacology +11

Broadening the phenotype of TARDBP mutations: the TARDBP Ala382Thr mutation and Parkinson’s disease in Sardinia

Marialuisa Quadri, Giovanni Cossu, Valeria Saddi et al. · Neurogenetics · 2011 · 86 citations · Full text

Life Sciences, Genetics, Neurology +17